EarthLink to Announce Third Quarter 2016 Results ATLANTA,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
EarthLink to Announce Third Quarter 2016 Results

ATLANTA, Oct. 17, 2016 (GLOBE NEWSWIRE) -- EarthLink Holdings Corp . (NASDAQ: ELNK ) today announced that it will host a conference call on Monday, Nov. 7, 2016 at 8:30 a.m. ET to discuss its third quarter 2016 financial results. EarthLink plans to issue its earnings press release before markets open on Nov. 7, 2016.

Conference Call Details Please note the toll-free dial-in number: 866-887-3882. Participants should reference the conference ID number 93635936 or "EarthLink Third Quarter 2016 Earnings Call" and dial in 10 minutes prior to the scheduled start time.

Webcast A live webcast of the conference call will be available at: http://ir.earthlink.net/ .

Replay A replay will be available from 11:30 a.m. ET on Nov. 7, 2016 through 11:59 p.m. ET on Dec. 6, 2016. Dial toll-free: 855-859-2056. The replay confirmation code is 93635936. Access the webcast archive on the company's website at: http://ir.earthlink.net/ .

About EarthLink EarthLink (EarthLink Holdings Corp., NASDAQ: ELNK ) is a leading network services provider dedicated to delivering great customer experiences. We help thousands of multi-location businesses securely establish critical connections in the cloud. Our solutions for cloud and hybrid networking , security and compliance , and unified communications provide the cost-effective performance and agility to serve customers anytime, anywhere, via any channel, or any device. We operate a nationwide network spanning 29,000+ fiber route miles, with 90 metro fiber rings and secure data centers that provide ubiquitous data and voice IP coverage. To learn why thousands of specialty retailers, restaurants, franchisors, financial institutions, healthcare providers, professional service firms, local governments, residential consumers and other carriers choose to connect with us, visit us at www.earthlink.com , @earthlink , on LinkedIn and Google+ .

Investors Trey Huffman 404-748-6219 678-571-1367 (mobile) huffmanal@elnk.com Media Randi Drinkwater 404-709-3404 randi.drinkwater@elnk.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Understanding Adobe’s Recent Options Activity Results

Updated Category News Views 114

Adobe's Options Activity Highlights In the world of finance, significant trades often signal important market sentiments. Recently, major investors have moved toward a bearish outlook on Adobe. Analyzing the options history for Adobe (NASDAQ: ADBE), we've identified a total of 67 significant trades. Our insights reveal that approximately 41% of these trades have been...

Continue Reading
Indonesia's Ongoing Challenge with Chinese Maritime Presence

Updated Category News Views 130

Indonesia's Maritime Security Efforts Intensify Recently, Indonesia's maritime security has been under increased scrutiny as incidents involving a Chinese coast guard vessel continue to escalate. This week, a Chinese vessel was driven from Indonesian waters not once, but twice, after interfering with a critical energy survey conducted by Pertamina, the state energy...

Continue Reading
Revolutionizing Game Development with Upheaval Games' Dreamer Portal

Updated Category News Views 140

Welcome to the Future of Game Development Upheaval Games, founded by veterans from the gaming industry, embraces a new frontier in game design with the introduction of The Dreamer Portal. This innovative web-based interface allows creators to effortlessly build immersive game content with just a simple prompt. Imagine the power of crafting unique creatures, items, and...

Continue Reading
Alvotech Moves Forward with Gobivaz® Approval in Europe

Updated Category News Views 190

Alvotech and Advanz Pharma Collaborate for Biosimilar Approval REYKJAVIK and LONDON – Alvotech (NASDAQ: ALVO), a renowned biotechnology firm, along with Advanz Pharma, a leading global pharmaceutical company, has shared important news regarding the marketing approval of Gobivaz®, a proposed biosimilar to Simponi® (golimumab). This biologic treatment is designed for...

Continue Reading
Exploring the Growth Potential of Remote Patient Monitoring Sector

Updated Category News Views 181

Remote Patient Monitoring Set for Dynamic Growth The increasing prevalence of chronic conditions worldwide is expected to significantly accelerate the growth of the remote patient monitoring (RPM) market. As conditions like hypertension, diabetes, and cardiovascular diseases become more common, coupled with an aging population, healthcare systems face immense pressure to...

Continue Reading